Hemophilia

Patients with bleeding disorder face liver disease from bloodborne pathogens

Published in AIDS Weekly, September 9th, 2002

by Sonia Nichols, senior medical writer - The cumulative incidence of hepatitis C virus (HCV)-related end-stage liver disease in patients with hemophilia increases with human immunodeficiency virus (HIV) coinfection, according to a report from the authors of the Multicenter Hemophilia Cohort Study.

Individuals from several medical and research facilities across the United States were enrolled in the ongoing multicenter study of hemophilia. One of the study's investigations focused on the nature of HCV-related end-stage liver disease in relation to transfusion-associated infections.

Both HIV and HBV have the capacity to be transmitted during...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-09-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry